Metabolic enzyme PFKFB3 mediates matrix stiffness‐potentiated tumour growth and radiotherapeutic resistance in HCC

Documenti analoghi

• Insights into the mechanisms, regulation, and therapeutic implications of extracellular matrix stiffness in cancer
  di: Ximo Zhang, et al.
  Pubblicazione: (2024)
• Targeting KDM4 family epigenetically triggers antitumour immunity via enhancing tumour‐intrinsic innate sensing and immunogenicity
  di: Mayu Sun, et al.
  Pubblicazione: (2024)
• The multifaceted roles of the ACSL family in cancer: Metabolic reprogramming, ferroptosis regulation and tumour immune microenvironment remodelling
  di: Haocai Li, et al.
  Pubblicazione: (2026)
• Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes
  di: Jiaqiang Xiong, et al.
  Pubblicazione: (2024)
• Deciphering of intra‐tumoural heterogeneity and the interplay between metastasis‐associated meta‐program and myofibroblasts in gastric cancer
  di: Xiongyan Wu, et al.
  Pubblicazione: (2025)